Barbara Kazmierczak, M.D., Ph.D., is a graduate of the University of Chicago who completed her M.D.-Ph.D. training at Weill Cornell University Medical College and the Rockefeller University. After internal medicine residency and infectious diseases fellowship training at the University of California, San Francisco, she joined the faculty at Yale where she is currently professor of medicine and professor of microbial pathogenesis. She was selected to lead Yale’s NIGMS-funded medical scientist training program in 2014. Kazmierczak has been active at the national level in the development of training programs for physician-scientists, serving as President of the National Association of M.D.-Ph.D. Programs, Chair of the AAMC GREAT section on M.D.-Ph.D. training, and member of the Association for Academic Internal Medicine’s Research Committee.

Kazmierczak is a practicing infectious diseases physician who leads a laboratory focused on the regulation and function of bacterial nanomachines and their recognition by innate immune receptors. She has been funded by NIH/NIAID for this work since 1999, with additional support from HHMI, the Donaghue Medical Research Foundation, the Burroughs Wellcome Fund, the Gates foundation and the Cystic Fibrosis Foundation. Kazmierczak is a fellow of the Infectious Diseases Society of America who has been elected to the American Society for Clinical Investigation (2014), the American Academy of Microbiology (2019) and the Connecticut Academy of Science and Engineering (2022). She currently serves as Director of the Gustavus and Louise Pfeiffer Research Foundation M.D.-Ph.D.